Unexpected Decision about Vaccination from Johnson & Johnson

Unexpected Decision about Vaccination from Johnson & Johnson An unexpected decision about vaccination came from the world-famous pharmaceutical company Johnson & Johnson. The company, which has been working on the vaccine, which is planned to be used in the treatment of the Covid19 disease for a while, temporarily stopped its studies due to an "unexplained disease" that occurred in one of the subjects. An unexpected development occurred in the vaccination studies conducted to combat the coronavirus epidemic that emerged in Wuhan, China and affected the whole world. In a statement made by the pharmaceutical company Johnson & Johnson, it was stated that the studies were stopped for a while due to an unexpected disease in one of the subjects. With this decision, for the second time in the race for viable virus development, a vaccine developer company stopped its work. New Jersey-based The New Brunswick made a statement late Monday, stating that the disease of the subject participating in the studies was investigated and that a statement will be made on this issue later in the ongoing research process. In J&J's statement on the subject, it is stated as follows "We undertake transparent updates throughout the development process of our vaccine candidate. Even if there are serious adverse events such as illness, accident, etc., such situations are possible in every clinical process, especially in such large-scale studies." Although the mishaps that occurred in the vaccine studies that were tried to be developed within the scope of the fight against the epidemic have been stopped, concerns in the pharmaceutical sector are increasing.